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Abstract: Three new compounds were isolated from the dried bulbs of Allium macrostemon 
Bunge. Their structures were elucidated from their spectral data as 
(25R)-26-O-β-D-glucopyranosyl-5α-furostane-3β,12β,22,26-tetraol-3-O-β-D-glucopyranos
-yl (1→2) [β-D-glucopyranosyl (1 →3)]-β-D-glucopyranosyl (1 →4)-β-D-galactopyranoside (1), 
(25R)-26-O-β-D-glucopyranosyl-5α-furostane-3β,12α,22,26-tetraol-3-O-β-D-gluco- pyranosyl 
(1→2) [β-D-glucopyranosyl (1→3)]-β-D-glucopyranosyl (1 →4)-β-D-galacto- pyranoside (2) and 
(25R)-26-O-β-D-glucopyranosyl-5β-furostane-3β,12α,22,26-tetraol-3-O-β-D-glucopyranosyl 
(1→2)-β-D-galactopyranoside (3), respectively. The inhibition effect of all compounds on 
CD40 ligand (CD40L) expression on the membrane of activated platelets stimulated by ADP 
was tested. Compounds 1 and 2 exhibited significant inhibitory activities in a dose dependent 
manner (P < 0.05), suggesting their potential application as CD40L inhibitors. 
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1. Introduction  
Recent reports suggest that most anti-platelet agents can be used as anti-inflammatory drugs and 
platelet activation is sometimes critical in the development of inflammation [1]. As a member of the 
tumor necrosis factor-α family of proteins, CD40L has been identified as a proinflammatory mediator 
and risk factor for cardiovascular events on activated platelets [2]. It can bind and activate platelet αⅡ bβ3 
in thrombosis and inflammation [3,4]. It is also able to activate endothelial cells to have a 
proinflammatory phenotype [5]. The stimulation of endothelial cells by platelets expressing CD40L 
contributes to inflammatory cell recruitment in atherosclerosis [6]. And the investigation on CD40L 
inhibitor would be significant and useful. 
It was reported that, as the main constituents of dried bulbs of Allium macorstemon Bunge, steroidal 
glycosides could strongly inhibit the platelet aggregation of human beings [7]. But their activity on 
platelet inflammatory was never reported. This paper concerns the isolation and structure elucidation of 
three new steroidal glycosides from ethanol extract of the dried bulbs of Allium macorstemon Bunge. 
Their inhibition on CD40L expression on the membrane of activated platelets was tested.  
2. Results and Discussion  
Compound 1 was isolated as an amorphous powder. The molecular formula was determined as 
C57H96O30 by the HR-ESIMS peak at m/z 1283.5862 [M+Na]+. The positive reaction to the Ehrlich 
reagent suggests a furostanol glycoside structure for 1 [8]. The 1H-NMR spectrum of 1 revealed the 
presence of four methyl groups at δ 1.34 (s, Me-18), 0.66 (s, Me-19), 1.60 (d, J = 6.8 Hz, Me-21) and 
0.97 (d, J = 6.8 Hz, Me-27) (Table 1).  
Table 1. 1H-NMR data of 1, 2 and 3 (C5D5N, δ ppm) a.  
No. 1 2 3 No. 1 2 3 
1 0.78,1.51 (o) 0.82, 1.51 (o) 1.51,1.80 (o) Inner Gal-1 
4.85(d,  
J = 7.8 Hz) 
4.84(d,  
J = 7.8 Hz) 
4.84(d,  
J = 7.6 Hz) 
2 1.24,1.99 (o) 1.25, 1.30 (o) 1.07,1.64 (o) 2 4.42(o) 4.43(o) 4.63(o) 
3 4.02(o) 3.80 (o) 4.28 (o) 3 4.19(o) 4.20(o) 4.20 (o) 
4 1.31,1.77 (o) 1.35, 1.75 (o) 1.51,1.80,(o) 4 4.58(m) 4.56(m) 4.54 (o) 
5 0.84(o) 0.92 (o) 2.19 (o) 5 4.16(o) 4.14(o) 3.96 (o) 
6 1.08,1.11 (o) 1.10, 1.60 (o) 1.19,1.87 (o) 6 4.21,4.68(o) 4.67,4.21(o) 4.39, 4.43(o) 
7 0.47,1.55 (o) 1.57, 1.99 (o) 1.31,1.89 (o) Gal-Glc-1 5.56(d,  J = 7.8 Hz) 
5.56(d,  
J = 7.8 Hz) 
5.25(d,  
J = 7.6 Hz) 
8 1.43(o) 1.57 (o) 1.66 (o) 2 4.38(o) 4.38(o) 4.06 (o) 
9 0.65(o) 1.33 (o) 2.11 (o) 3 4.19(o) 4.17(o) 4.16 (o) 
10 ---- ------ ---- 4 3.84(o) 3.86(o) 4.29 (o) 
11 1.49,1.82 (o) 1.63, 1.78 (o) 1.63,1.72 (o) 5 4.13(o) 4.13(o) 3.93 (o) 
12 3.52(m) 3.98 (o) 4.21 (o) 6 4.51(o) 4.50(o) 4.38, 4.43 (o) 
13 ---- ------ ---- 3-Glc-1 5.28(d,  J = 7.8 Hz) 
5.29(d,  
J = 7.8 Hz)  
14 1.13(o) 2.06 (o) 2.12 (o) 2 4.02(o) 4.00(o)  
15 1.52,2.08 (o) 0.89 (o) 1.53,2.13 (o) 3 3.84(o) 3.85(o)  
16 5.02(o) 5.02 (o) 5.04 (m) 4 4.23(o) 4.23(o)  
17 2.31(t,  J = 8.2 Hz) 
3.21 (dd,  
J = 7.2,  
8.3 Hz) 
3.22 (dd,  
J = 6.8,  
8.7 Hz) 
5 3.85(o) 3.83(o)  
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Table 1. Cont. 
18 1.34 (s) 0.99 (s) 0.99 (s) 6 4.18,4.27(o) 4.18,4.27(o)  
19 0.66(s) 0.68 (s) 1.02 (s) 2-Glc-1 4.77(d,  J = 7.8 Hz) 
4.76(d,  
J = 7.8 Hz)  
20 2.48(m) 2.28 (o) 2.29 (m) 2 4.08(o) 4.09(o)  
21 1.60(d,  J = 6.8 Hz) 
1.38(d,  
J = 6.8 Hz) 
1.36(d,  
J = 6.8 Hz) 3 4.21(o) 4.21(o)  
22 ---- ------ ---- 4 4.17(o) 4.18(o)  
23 2.08(o) 2.10 (o) 2.04, 2.06 (o) 5 3.92(o) 3.92(o)  
24 1.69,2.08 (o) 1.70, 2.08 (o) 1.71, 2.06 (o) 6 4.20,4.00(o) 4.21,4.00(o)  
25 1.91(o) 1.93 (o) 1.94 (o) C26 Glc-1 
5.13(d,  
J = 7.8 Hz) 
5.12(d,  
J = 7.8 Hz) 
4.80(d,  
J = 7.6 Hz) 




4.00 (m) 2 4.00(o) 4.01(o) 4.22 (o) 
27 0.97(d,  J = 6.8 Hz) 
0.99(d,  
J = 6.8 Hz) 
0.99(d,  
J = 6.8 Hz) 3 4.03(o) 4.04(o) 3.83 (o) 
    4 4.23(o) 4.23(o) 3.99 (o) 
    5 4.17(o) 4.16(o) 4.22 (o) 
    6 4.20,4.49(o) 4.20,4.47 (o) 4.37,4.52 (o) 
a Recorded on a Bruker-400 NMR spectrometer. 
 
The anomeric region of the 1H-NMR spectrum showed five anomeric proton signals at δH 4.77 (d,  
J = 7.8 Hz), 4.85 (d, J = 7.8 Hz), 5.13 (d, J = 7.8 Hz), 5.28 (d, J = 7.8 Hz) and 5.56 (d, J = 7.8 Hz), 
respectively. Large coupling constants (3J1, 2 = 7.8 Hz) for anomeric protons revealed the β-configuration 
of all sugars. The 13C-NMR and DEPT spectra showed 57 carbon signals, including four methyls, 35 
methylenes, 15 methines and three quaternary carbons (Table 2).  
Table 2. 13C-NMR data of 1, 2 and 3 (C5D5N, δ ppm)a. 
No. 1 2 3 No. 1 2 3 
1 37.1 37.0 30.8 Inner Gal-1 102.4 102.3 102.3 
2 29.8 29.9 26.8 2 73.1 73.1 81.7 
3 75.1 77.5 75.1 3 75.5 75.5 75.1 
4 34.7 34.8 30.9 4 80.1 80.2 69.8 
5 44.7 44.8 37.0 5 76.1 76.1 76.5 
6 28.9 29.0 27.1 6 60.5 60.5 62.1 
7 32.2 29.8 26.7 Gal-Glc-1 104.8 104.9 106.0 
8 34.3 35.6 35.9 2 81.4 81.4 76.8 
9 53.5 47.8 33.7 3 88.4 88.4 78.0 
10 35.8 35.5 34.9 4 70.8 70.8 71.7 
11 31.6 29.5 29.6 5 77.8 77.8 78.4 
12 79.3 71.5 71.7 6 62.3 62.3 62.8 
13 46.8 45.6 45.8 3-Glc-1 104.5 104.5  
14 55.0 48.3 48.6 2 75.1 75.1  
15 32.1 32.5 32.5 3 78.6 78.6  
16 81.1 80.9 81.0 4 70.9 70.9  
17 63.7 54.5 54.6 5 77.5 77.4  
18 11.3 17.4 17.5 6 62.7 62.3  
19 12.2 12.2 23.9 2-Glc-1 104.8 104.8  
20 41.6 40.9 40.9 2 75.1 75.2  
21 15.6 16.2 16.2 3 78.6 78.6  
22 110.8 110.6 110.7 4 71.7 71.7  
23 37.3 37.2 37.2 5 78.4 78.6  
24 28.4 28.4 28.4 6 62.8 62.8  
25 34.2 34.2 34.3 C26 Glc-1 105.0 105.0 104.9 
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Table 2. Cont. 
26 75.2 75.3 75.3 2 75.2 75.3 75.1 
27 17.4 17.4 17.4 3 78.6 78.6 78.3 
    4 71.5 71.5 71.6 
    5 78.5 78.4 78.5 
    6 63.0 63.0 62.8 
a Recorded on a Bruker-400 (100 MHz for 13C) NMR spectrometer. 
Comparison of the 13C-NMR data of 1 and those of the reported compound ((25R) 26-O-β 
-D-glucopyranosyl-3β ,22 ,26-trihydroxyl-5afurostane-3-O-β -chacotrioside)[8] suggested a 
considerable structural similarity except for the carbon signals around C-12. Comparison of the 
aglycone to the reported compound indicated the existence of a β-hydroxyl group at C-12, which led to 
the similar 13C-NMR shifts of the carbons C-11, C-12 and C-13 [9,10]. This was also supported by 
HMBC correlations (Figure 1) between the proton signal at δH 1.34 (H-18) and carbon signal at δC 79.3 
(C-12). The 25R configuration was determined by the chemical shifts of C-23 (δC 37.3), C-24 (δC 28.4), 
C-25 (δC 34.2), C-26 (δC 75.2) and C-27 (δC17.4) [11,12]. This was also confirmed by the difference 
between the chemical shifts of two proton signals of H-26 (0.29) since the difference is usually >0.57 
for (25S) configurations and <0.48 for (25R) configurations [13]. The chemical shifts of C-5 (δC 44.7), 
C-9 (δC 53.5) and C-19 (δC 12.2) were consistent with those of the 5α-steriodal glycosides [8, 10, 14], 
indicating the H-5α configuration. 





























     
 
 
Acid hydrolysis of 1 yielded D-glucose and D-galactose in a ratio of 4:1. The HMBC correlations 
from δH 4.85 (H-1 of inner galactose attached to C-3 of the aglycone) to δC 75.1 (C-3 of aglycone), from 
δH 5.56 (H-1of inner glucose) to δC 80.1 (C-4 of inner galactose), from δH 5.28 (H-1of terminal glucose 
attached to inner glucose) to δC 88.4 (C-3 of inner glucose), from δH 4.77 (H-1of terminal glucose 
attached to inner glucose) to δC 81.4 (C-2 of inner glucose) and from δH 5.13 (H-1 of terminal glucose 
attached to C-26) to δC 75.2 (C-26 of aglycone) indicated that two sugar chains were attached to C-3 and 
C-26 of the aglycone, respectively. A terminal glucose was attached at C-26. The inner glucose was 
linked at C-4 of the inner galactose attached to C-3 and two terminal glucoses were linked at C-3 and C-2 
of the inner glucose. The combined use of 1H-1H COSY, HSQC, TOCSY and HMBC experiments 
allowed the sequential assignments of all resonances for each monosaccharide. Compound 1 was thus 
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identified as (25R)-26-O-β-D-glucopyranosyl-5α-furostane-3β,12β,22,26-tetraol-3-O-β-D-gluco- 
pyranosyl(1→2) [β-D-glucopyranosyl (1→3)] -β-D-glucopyranosyl (1→4) -β-D-galactopyranoside 
(Figure 2). 
Compound 2 was isolated as a white amorphous powder. The same molecular formula of C57H96O30 
as 1 was deduced by the positive-ion HR-ESIMS signal at m/z 1283.5891 [M+ Na]+. Comparison of 
1H-NMR and 13C-NMR spectra for the sugar moieties of 2 with those of 1 suggested the same sugar 
chains. The 13C-NMR data for the aglycone of 2 showed considerable similarity to 1 except for the 
signals around C-12. The long rang correlations of HMBC between methyl proton signal at δH 0.99 
(H-18) and carbon signal at δC 71.5, proton signal at δH 3.98 (H-12) and carbon signal at δC 29.5 (C-11) 
and 45.6 (C-13) revealed the presence of hydroxyl group at C-12. The NOESY correlation between δH 
3.98 (H-12) and δH 0.99 (H-18) suggested its α-orientation. The presence and configuration of C-12 
hydroxyl group was also supported by carbon signals of C-11, C-12, C-13, C-14 and C-17 of 2 shifted 
higher field by approximately – 2.1, - 7.8, - 1.2, - 6.7 and - 9.2 ppm, respectively, while the carbon signal 
of C-18 shifted to down field by +6.1 ppm comparing with those of 1. Therefore, the structure of 2 was 
established as (25R)-26-O-β-D-glucopyranosyl-5α-furostane-3β,12α,22,26-tetraol-3-O-β-D-gluco- 
pyranosyl (1→2) [ β-D-glucopyranosyl (1→3)] -β-D-glucopyranosyl (1→4) -β-D-galactopyranoside 
(Figure 2).   

















































































Compound 3 was obtained as a white amorphous powder. The molecular formula of 3 was defined as 
C45H76O20 on the basis of the HRESI-MS signal at m/z 937.5075 [M+H]+. 1H-NMR and 13C-NMR data 
for the aglycone moieties of 3 was similar to those of 2, except for the signals of A/B ring portion. In the 
13C-NMR spectrum, the higher field chemical shift of the A/B ring of 3 and the downfield chemical shift 
of C-19 revealed the β-orientation of H-5. This was also confirmed by NOESY correlation between 
proton signals at δ 2.19 (H-5) and 1.02 (H-19). The 1H-NMR and 13C-NMR spectra of 3 showed three 
anomeric protons at δH 4.80 (d, J = 7.6 Hz), 4.84 (d, J = 7.6 Hz) and 5.25 (d, J = 7.6 Hz) and three 
anomeric carbons at δC 104.9, 102.3 and 106.0, suggesting that there were only three sugar units in 3 and 
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the same large constants (3J1,2 = 7.6 Hz) for anomeric protons revealed the β-configuration of all these 
sugars. Acid hydrolysis of 3 yielded D-glucose and D-galactose in a ratio of 2:1. In the HMBC spectrum, 
long-range correlations from δH 4.84 (H-1 of inner galactose) to δC 75.1 (C-3 of aglycone), from δH 5.25 
(H-1 of terminal glucose) to δC 81.7 (C-2 of inner galactose) and from δH 4.80 (H-1 of terminal glucose 
attached to C-26) to δC 75.3 (C-26 of aglycone) showed that two sugar chains were separately attached to 
C-3 and C-26 of the aglycone, and two glucoses were linked at C-2 of the inner galactose attached at C-3 
and C-26 of aglycone respectively. Thus, the structure of 3 was established as (25R)-26-O-β-D- 
glucopyranosyl-5β-furostane-3β,12α,22,26-tetraol-3-O-β-D-glucopyranosyl(1 →2)-β-D-galactopyranoside 
(Figure 2). 
The inhibitory effect of compounds 1-3 of CD40 ligand (CD40L) expression on the membrane of 
activated platelets stimulated by ADP was measured by real time PCR. Compounds 1 and 2 exhibited 
significantly inhibit expressions of CD40L in ADP induced active platelets in a dose dependent manner 
(P < 0.05) (Figure 3) which suggested that they may be new type of CD40L inhibitors for curing platelet 
inflammatory related diseases. 
Figure 3. Inhibitory effect of the compounds 1-3 on CD40 ligand (CD40L) expression on 
the membrane of activated platelets stimulated by ADP. 
         






















3. Experimental  
3.1. General  
Melting points were determined with a Yanaco MP-S3 micro-melting point apparatus and are 
uncorrected. Optical rotations were obtained on a P-1020 digital polarimeter (JASCO Corporation). IR 
spectra were measured on a Shimadzu FT/IR-8400 spectrometer. 1D and 2D NMR spectra were taken 
on a Bruker AV-400 (400 MHz for 1H-NMR) spectrometer in C5D5N solution. ESIMS spectra were 
acquired using a Bruker Esquire 2000 mass spectrometer. Column chromatography was carried out on 
Diaion HP-20 (Mitsubishi Kasei, Japan), silica gel (200–300 mesh, Qingdao Factory of Marine 
Chemical Industry, Qingdao, China) and ODS (40-63 µm, Merck). TLC analyses were taken on Silica 
gel 60F254 (Qingdao Factory of Marine Chemical Industry, Qingdao, China) and the spots were detected 
spraying with Ehrlich reagent and heating. Preparative HPLC was performed using an ODS column 
(250 × 20 mm, 10 μm, Shimadzu Pak; Detector: RID). Quantitative real-time PCR was performed using 
the PE5700 PCR system (Biosystems, Foster, CA, USA). The Qiagen RNeasy minikit system (Qiagen, 
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Valencia, CA, USA) was used to collect mRNA from ADP induced active platelets. The mRNA was 
converted to cDNA using the AMV Reverse Transcription System (Promega, Madison, Wi, USA). 
3.2. Plant material 
The bulbs of Allium Macrostemon Bunge were purchased from Liaoning Province of China and 
identified by Professor Qi-Shi Sun (Department of Pharmacognosy, Shenyang Pharmaceutical 
University). The voucher specimen has been deposited at the Department of Natural Product Chemistry, 
Shenyang Pharmaceutical University, Shenyang (110016), P. R. China. 
3.3. Extraction and isolation 
The dried bulbs of Allium Macrotemon Bunge (5 kg) were extracted twice with 60% ethanol (10 L) 
for 2 h each time. The ethanol extraction was concentrated under reduced pressure, suspended in water 
and then passed through Diaion HP-20 column using EtOH/H2O gradient system (0–100%). The 60% 
EtOH eluted fraction (90 g), which was subjected to silica gel column chromatography with 
CHCl3/MeOH/H2O (9:1:0.1; 8:2:0.2; 7:3:0.5: 6:4:0.8, v/v/v) and MeOH finally, gave nine fractions. 
Fraction 2 was further purified by ODS column chromatography eluting with MeOH/H2O (3:7; 2:3; 1:0, 
v/v) to afford five sub fractions. The third subfraction was also further purified by repeated Rp-18 HPLC 
preparation, eluting with MeOH/H2O (50:50, v/v), to yield 1 (8.1 mg), 2 (8.5 mg) and 3 (30.6 mg).  
 
Compound 1((25R)-26-O-β-D-glucopyranosyl-5α-furostane-3β,12β,22,26-tetraol-3-O-β-D-gluco- 
pyranosyl(1→2) [β-D-glucopyranosyl (1→3)] -β-D-glucopyranosyl (1→4) -β-D-galactopyranoside). 
White amorphous powder, m.p. 216–217 ºC, [α]21 D  -26.4° (H2O, c 0.11). HR-ESIMS (positive mode) at 
m/z 1283.5862 [M+ Na]+ (calcd. 1283.5884). ESI-MS (positive mode) at m/z 1283 [M+ Na]+, 1265 [M+ 
Na- H2O]+, 1121 [M+ Na- 162]+, 1103 [M+ Na- H2O- 162]+, 941 [M+ Na- H2O- 162× 2]+, 779 [M+ Na- 
H2O- 162× 3]+; ESI-MS (negative mode) at m/z 1259 [M- H]-, 1097 [M- H- 162]-, 935 [M- H- 162× 2]-, 
773 [M- H- 162× 3]-, 611 [M- H- 162× 4]-; IR νmax (KBr) cm-1: 3419 (OH), 2937 (CH), 1000-1100; 
1H-NMR (C5D5N) data see Table 1; 13C-NMR, see Table 2. 
 
Compound 2 ((25R)-26-O-β-D-glucopyranosyl-5α-furostane-3β,12α,22,26-tetraol-3-O-β-D-gluco- 
pyranosyl (1→2) [ β-D-glucopyranosyl (1→3)] -β-D-glucopyranosyl (1→4) -β-D-galactopyranoside). 
White amorphous powder, m.p. 177–178 ºC, [α]21 D  -3.5° (H2O, c 0.16). HR-ESIMS (positive mode) at 
m/z 937.5075 [M+ H]+ (calcd. 937.5008). ESI-MS (positive mode) at m/z 959 [M+ Na]+, 941 [M+ Na- 
H2O]+, 919 [M+ H- H2O]+, 797 [M+ Na- 162]+, 617 [M+ Na- H2O- 162× 2]+, 595 [M+ H- H2O- 162× 
2]+, 433 [M+ H- H2O- 162×2- 162]+; ESI-MS (negative mode) at m/z 935 [M- H]-, 773 [M- H- 162]-, 611 
[M- H- 162× 2]-; IR νmax (KBr) cm -1: 3415 (OH), 2925 (CH), 1045; 1H-NMR (C5D5N) data see Table 1; 
13C-NMR, see Table 2. 
 
Compound 3 ((25R)-26-O-β-D- glucopyranosyl-5β-furostane-3β,12α,22,26-tetraol-3-O-β-D- 
glucopyranosyl(1→2)-β-D-galactopyranoside). White amorphous powder, m.p. 215–216 ºC, [α] 21 D  
-28.7° (H2O, c 0.12). HR-ESIMS (positive mode) at m/z 1283.5891 [M+Na]+ (calcd 1283.5884). 
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ESI-MS (positive mode) at m/z 1283 [M+ Na]+, 1121 [M+ Na- 162]+, 959 [M+ Na- 162× 2]+, 797 [M+ 
Na- 162× 3]+, 779 [M+ Na- 162× 3- H2O]+; ESIMS (negative mode) at m/z 1259 [M- H]-, 1097 [M- H- 
162]-, 935 [M- H- 162× 2]-, 773 [M- H- 162× 3]-, 611 [M- H- 162× 4]-; IR νmax (KBr) cm -1: 3429 (OH), 
2933 (CH), 1039; 1H-NMR (C5D5N) data see Table 1; 13C-NMR, see Table 2. 
3.4. Acid hydrolysis of saponins 
Each glycoside (5 mg) was heated in an ampoule with 15% aq. HCl (5 mL) at 110 ºC for 2 h. The 
aglycone was extracted with dichloromethane three times and the aqueous residue was evaporated under 
reduced pressure. Then, pyridine (1 mL) and NH2OH·HCl (2 mg) were added to the residue, and the 
mixture was heated at 100 ºC for 1 h. After cooling, Ac2O (0.5 mL) was added and the mixtures were 
heated at 100 ºC for 1 h. The reaction mixtures were evaporated under reduced pressure, and the 
resulting aldononitrile peracetates were analyzed by GC-MS using standard aldononitrile peracetates as 
reference samples. D-glucose and D-galactose were identified in a ratio of 4:1 for compound 1 and 2 
and in a ratio of 2:1 for compound 3.  
3.5. Platelets preparation 
After obtaining consent, blood samples were collected from healthy volunteers (five men and five 
women; age range, 17–45 years) and 3.8% sodium citrate (nine parts blood, one part citrate) was added 
as an anticoagulant. All subjects avowed that they had not taken any anti-platelet drug at least 2 weeks 
prior to the extraction. Platelet-rich plasma (PRP) was prepared by centrifugation at 125×g for 10 min at 
room temperature. Platelet count was adjusted to 5 × 109 platelets/mL. PRP (400 µL) was added to the 
wells of a tissue-culture plate (24-well plate; well size 16 × 16 mm; Nunc) and pretreated with 
compounds (5, 20, 80, 320 µM) or AR-C67085MX (10 µM) at 37 ºC for 10 min, and then stimulated 
with 20 µM ADP for 5 min.  
3.6. Real-time reverse-transcriptase-polymerase chain reaction 
The mRNA was collected from ADP induced active platelets following the manufacturers' 
recommended protocol. The mRNA was converted to cDNA and cDNA samples were kept at -20 ºC 
until needed. The CD40L and housekeeping gene β-actin primers for PCR analysis were based on the 
human platelet sequences and designed using the Primer 5 software. The forward and reverse primers 
were as follows: 
CD40L mRNA: 5′ACATACAACCAAACTTCTCCC 3′ and 5′AGATGTTGTTTTACTGCTGGC 
3′, (799 bp) 
β-actin mRNA: 5’-AAGGATTCCTATGTGGGC-3’ and  5’-CATCTCTTGCTCGAAGTC-3, (362 
bp) 
The reaction mixture contained TaqMan universal PCR Master Mix (25 μL), 10 μM (2 μL) of each 
primer, TaqMan probe (2.5 μL) and cDNA (2 μL). It was adjusted to 22.5 μL with DNase/RNase free 
water. Conditions of the real-time-PCR were as follows: 50 ºC for 2 min, 95 ºC for 15 min, and for 40 
cycles, 95 ºC for 15 s and 60 ºC for 1 min. The Ct value is defined as the number of fractional cycles in 
which the fluorescence emitted by the reaction mixture exceeds a preset threshold and marks the 
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beginning of an exponential growth of the fluorescence signal. The results were analyzed with PE  
5700 software. 
 
3.7. Statistical analysis 
All results were expressed as the mean±standard error (SE). Analyses were performed with SPSS 
software Version 13.0 (SPSS, Chicago, IL). ANOVA was used to determine if significant variation 
existed between group means. Two-side p values less than 0.05 were considered to be significantly. 
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